← Insider buys
PVLA

Palvella Therapeutics, Inc. · Healthcare

Director George M Jenkins sold $4.2M of Palvella Therapeutics, Inc.

Sold$4,167,146
$151.53Price
27,500Shares
−15%Stake

What PVLA did after the filing

Filed Sep 15Copier in Sep 16
The stock from Wed, Sep 16 open, $152.54
−18.0%
S&P 500, same days
+0.1%

27 of 30 trading days so far, to the Oct 23 close.

Traded Fri, Sep 11. Filed Tue, Sep 15, 9:15 PM ET, after the close. Returns use the Sep 16 open and the Oct 23 close. Not investment advice.